Beta-catenin and periostin in interstitial pneumonia (IP) of extrinsic (EIP) and unknown (IIP) origin

G. Orlova (St. Petersburg, Russian Federation), E. Surkova (St. Petersburg, Russian Federation)

Source: Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases
Session: Chronic airway, interstitial, pleural and neoplastic diseases
Session type: E-poster
Number: 3359

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Orlova (St. Petersburg, Russian Federation), E. Surkova (St. Petersburg, Russian Federation). Beta-catenin and periostin in interstitial pneumonia (IP) of extrinsic (EIP) and unknown (IIP) origin. 3359

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip
Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Year: 2007


Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB)
Source: Eur Respir J 2006; 28: Suppl. 50, 308s
Year: 2006

Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012

Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Differences in pulmonary function tests (PFTs) in patients with usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001

The clinical significance of markers of endothelial dysfunction (ED) inprogression of idiopathic interstitial pneumonias (IIP)
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011

Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Clinical presentation on nonspecific (NSIP) compared to usual (UIP) interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001

Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

Safety of sputum induction (SI) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Apoptosis, cell proliferation and angiogenesis in progression of different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 573s
Year: 2007

Non-specific interstitial pneumonia (NSIP) - a study of 12 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Peripheral blood changes in usual interstitial pneumonia (UIP) and non specific interstitial pneumonia (NSIP), possible biomarkers of oxidative stress
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Idiopathic interstitial pneumonia (IIP) - optimal timing for initiating treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 535s
Year: 2004

Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

LATE-BREAKING ABSTRACT: Morphology and molecular basis of damage stem cell niche respiratory acini (SCNRA) in idiopathic interstitial pneumonia (IIP)
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016


Histology and pathogenesis of usual interstitial pneumonia (UIP) versus nonspecific interstitial pneumonia (NSIP): progressive remodeling or resolution and healing?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006


Osteopontin role in community-Acquired Pneumonia (CAP).
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

UIP-like or NSIP pattern in interstitial lung disease patients (ILD), following by ‘connective tissue disease ‘(CTD)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012